Oct. 25, 2018
Monsanto's high-stakes glyphosate battle is just beginning
In the next few weeks, Dewayne Johnson’s lawyers will have to decide whether to accept the judge’s $210 million reduction of the jury’s award.
David I. Levine
Professor
UC Law San Francisco
Professor Levine is author, coauthor, or coeditor of over sixty editions of his seven books, including Remedies: Public and Private and California Civil Procedure, as well as the author of articles on civil procedure, torts and institutional reform litigation. He has served as the Reporter for the District of Nevada's Committee on the Implementation of the Civil Justice Reform Act, and as a research analyst for the Northern District of California's Early Neutral Evaluation Program; he is an Advisor for the American Law Institute's Restatement (Third) of the Law of Torts: Remedies.
There were headlines around the world in August when a San Francisco County Superior Court jury held Monsanto Co. (now a subsidiary of Bayer A.G.) responsible for Dewayne "Lee" Johnson's non-Hodgkin's lymphoma and awarded the eye-popping figure of more than $289 million in compensatory ($39.25 million) and punitive damages ($250 million). Johnson v. Monsanto et. al.,...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Tax, Civil Litigation
Monsanto weed killer verdict highlights unfair tax rules, again
By Robert W. Wood
Civil Litigation
Judge leaning toward excluding some Monsanto expert testimony
By Winston Cho
Civil Litigation
In tentative ruling, judge orders new trial on punitive damages in Monsanto case
By Winston Cho
